查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564044

乳房病变定位全球市场

Breast Lesion Localization
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

至2030年，全球乳房病变定位市场预计将达到4.302亿美元

Masu 表示，2023 年全球乳房病变定位市场预计为 3.158 亿美元，预计到 2030 年将达到 4.302 亿美元，2023-2030 年的复合年增长率为 4.5%。乳房切片是本报告分析的细分市场之一，复合年增长率为 5.0%，预计到分析期结束时将达到 3.092 亿美元。在分析期间，灯切除术领域的复合年增长率估计为 3.3%。

美国市场预估为8,580万美元，中国预期复合年增长率为4.2%

到 2023 年，美国乳房病变定位市场预计将达到 8,580 万美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 6,780 万美元，2023-2030 年分析期间复合年增长率为 4.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.3% 和 3.7%。在欧洲，德国的复合年增长率预计约为 4.5%。

全球乳房病变局部市场 - 主要趋势和驱动因素总结

为什么乳房病变的定位在现代医学中很重要？

乳房病变的定位是乳癌治疗的重要步骤，尤其是早期检测和治疗计划。但这个程序涉及什么？基本上，它标记乳房组织内的可疑区域，以在切片检查或手术期间指导外科医生。随着全球乳癌发生率的增加，准确定位的重要性只会越来越高。传统方法，例如透过插入导线来标记病灶的导线定位，已经使用了数十年，但正在被更先进的技术所取代。这些新方法更加精确、不那么不舒服，并且可以更有效地针对小的或不可触及的病变，从而大大改善患者的治疗效果。借助超音波、乳房X光摄影和磁振造影（MRI）等先进技术指南这些手术，医疗界比以往任何时候都更有能力进行有针对性的干预，最大限度地减少组织损伤并提高康復率。

乳房病灶定位技术有哪些进展？

近年来，乳房病变定位技术取得了重大进展。从历史上看，线导定位（WGL）一直是黄金标准。然而，雷达定位、RFID（无线射频识别）和磁种子等无线定位技术的出现，提供了更简化和高效的程序。例如，雷达照射使用雷达波精确瞄准病变，而不会带来与电线相关的不适或限制。 RFID标籤是植入病变部位的小型标籤，可以长时间留在原处，从而实现更灵活的调度。另一种创新方法是磁性种子定位，涉及将小的磁性种子插入病变中，在手术过程中可以轻鬆检测到。这些技术对于无法触及病变的患者特别有益，减少了因错误触诊而重新手术的需要，并提高了患者体验和医生的准确性。向侵入性较小、更精确的技术的转变凸显了个人化医疗的更广泛趋势，其中精确性和患者舒适度至关重要。

不断变化的指南和患者需求如何影响乳房病变的定位？

乳房病变定位的临床前景正在受到几个重要趋势的影响，包括医疗指南的更新和患者期望的变化。美国乳房外科医师协会（ASBrS）等组织的指引强调需要进行最小切缘的局部切除，这直接影响局部切除方法的选择。外科医生越来越多地寻求能够提供即时回馈、提高精度并确保切除恶性组织的高可信度的技术。随着患者寻求侵入性较小的治疗方法以减少焦虑和不适，以患者为中心的照护也成为关键因素。对更灵活的调度和缩短时间的需求刺激了消除传统线引导定位限制的技术的采用，其中定时对于确保线稳定性至关重要。因此，可以在手术前几天植入的无线立体定位技术为患者和医疗保健提供者提供了便利和安心。

乳房病变定位市场的主要成长动力是什么？

乳房病变定位市场的成长是由多种因素推动的，反映出对更先进和患者友善技术的需求不断增长。首先，RFID、磁性种子和雷达等无线定位方法的技术进步提高了准确性和病患舒适度，促使医疗机构采用这些创新。其次，全球乳癌发生率不断上升，增加了对精确定位技术作为早期检测和治疗策略一部分的需求。第三，不断发展的医疗保健政策和对基于价值的护理的日益关注正在鼓励医院投资于能够提供更好的结果、更少的併发症并符合现代医疗保健报销模式的技术。此外，新兴国家的人口老化和乳癌筛检率的提高正在为市场开拓创造新的机会。最后，患者对微创手术和允许更灵活安排的技术的偏好正在加速远离线引导技术，进一步推动对创新乳房病变定位解决方案的需求。这些因素共同改变了乳房病变定位的格局，并创造了一个优先考虑技术进步、患者体验和改善临床结果的市场。

调查企业范例（共43例）

  • Argon Medical Devices, Inc.
  • BARD, A Becton, Dickinson Company
  • Cianna Medical, Inc.
  • Cook Medical LLC
  • CP Medical Corporation
  • Somatex Medical Technologies GmbH
  • Sterylab Srl

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10796

Global Breast Lesion Localization Market to Reach US$430.2 Million by 2030

The global market for Breast Lesion Localization estimated at US$315.8 Million in the year 2023, is expected to reach US$430.2 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of the analysis period. Growth in the Lumpectomy segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.8 Million While China is Forecast to Grow at 4.2% CAGR

The Breast Lesion Localization market in the U.S. is estimated at US$85.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.8 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Breast Lesion Localization Market - Key Trends and Drivers Summarized

Why Is Breast Lesion Localization Critical in Modern Medicine?

Breast lesion localization is a vital step in the management of breast cancer, especially for early detection and treatment planning. But what does this procedure entail? Essentially, it involves marking suspicious areas within the breast tissue to guide surgeons during biopsy or surgery. As breast cancer rates rise globally, the importance of accurate localization methods has only increased. Traditional methods such as wire localization, where a wire is inserted to mark the lesion, have been used for decades but are being phased out in favor of more advanced techniques. These new approaches offer higher precision, less discomfort, and more effective targeting of smaller or non-palpable lesions, greatly enhancing patient outcomes. With evolving technologies like ultrasound, mammography, and magnetic resonance imaging (MRI) guiding these procedures, the medical community is better equipped than ever to perform targeted interventions, minimizing damage to surrounding tissues and improving recovery rates.

What Are The Advancements in Breast Lesion Localization Technology?

In recent years, breast lesion localization technologies have undergone significant evolution. Historically, wire-guided localization (WGL) was the gold standard. However, non-wire alternatives like radar localization, radiofrequency identification (RFID), and magnetic seeds have emerged, offering more streamlined and efficient procedures. For instance, radar localization uses radar waves to precisely target lesions without the discomfort or limitations associated with wires. RFID tags, which involve implanting a small tag into the lesion, allow for more flexible scheduling as they can remain in place for longer periods. Magnetic seed localization, another innovative method, involves inserting a small magnetic seed into the lesion, which can then be easily detected during surgery. These technologies are especially beneficial for patients with non-palpable lesions, reducing the need for repeated surgeries due to mislocalization and enhancing both the patient's experience and the physician’s accuracy. The shift toward minimally invasive, highly accurate techniques underscores a broader trend in personalized medicine, where precision and patient comfort are paramount.

How Are Changing Guidelines and Patient Needs Shaping Breast Lesion Localization?

The clinical landscape for breast lesion localization has been shaped by several key trends, including updated medical guidelines and changing patient expectations. Guidelines from organizations like the American Society of Breast Surgeons (ASBrS) emphasize the need for localized excision with minimal margins, which directly impacts the choice of localization methods. Surgeons are increasingly seeking techniques that provide real-time feedback, enhance accuracy, and ensure a high degree of confidence in the excision of malignant tissue. Patient-centric care has also emerged as a defining factor, as patients seek minimally invasive options that reduce anxiety and procedural discomfort. The demand for more flexible scheduling and reduced time between diagnosis and surgery has spurred the adoption of technologies that eliminate the constraints imposed by traditional wire-guided localization, where timing was critical to ensure wire stability. As a result, non-wire localization methods, which can be implanted days before surgery, provide more convenience and peace of mind for both patients and healthcare providers.

What Are The Key Growth Drivers In The Breast Lesion Localization Market?

The growth in the breast lesion localization market is driven by several factors, reflecting the increasing demand for more advanced, patient-friendly technologies. First, technological advancements in non-wire localization methods, such as RFID, magnetic seeds, and radar, have improved both accuracy and patient comfort, pushing healthcare facilities to adopt these innovations. Second, the rising incidence of breast cancer globally has led to a greater need for precise localization techniques as part of early detection and treatment strategies. Third, evolving healthcare policies and the increasing focus on value-based care have encouraged hospitals to invest in technologies that offer better outcomes with fewer complications, aligning with modern medical reimbursement models. Additionally, the aging population and increased breast cancer screening rates in developing countries are creating new opportunities for market expansion. Lastly, patient preferences for minimally invasive procedures and technologies that allow for more flexible scheduling have accelerated the shift away from wire-guided methods, further driving the demand for innovative breast lesion localization solutions. Together, these factors are transforming the landscape of breast lesion localization, fostering a market that prioritizes technological advancements, patient experience, and improved clinical outcomes.

Select Competitors (Total 43 Featured) -

  • Argon Medical Devices, Inc.
  • BARD, A Becton, Dickinson Company
  • Cianna Medical, Inc.
  • Cook Medical LLC
  • CP Medical Corporation
  • Somatex Medical Technologies GmbH
  • Sterylab Srl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Breast Lesion Localization - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Breast Cancer Globally Drives Demand for Accurate and Efficient Localization Technologies
    • Advancements in Non-Wire Localization Techniques Propel Growth in Breast Lesion Localization Market
    • Increased Adoption of Radiofrequency Identification (RFID) and Magnetic Seed Localization Expands Addressable Market Opportunities
    • Adoption of Image-Guided Localization Techniques Accelerates Market Growth
    • Growing Focus on Reducing Re-Excision Rates and Improving Surgical Outcomes Propels Demand for Advanced Localization Tools
    • Surge in Demand for Targeted Breast Surgeries and Personalized Treatment Plans Drives Adoption of Localization Technologies
    • Here's How Advances in Magnetic Seed and Radar Localization Techniques are Creating New Market Opportunities
    • Increased Awareness of Breast Cancer Screening Programs Globally Generates New Opportunities for Localization Technologies
    • Rising Adoption of RFID Localization in Complex Breast Surgeries Spurs Technological Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Breast Lesion Localization Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Breast Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Lumpectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Lumpectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Wire Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Wire Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Magnetic Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Radioisotope Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Radioisotope Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Method Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Other Method Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • JAPAN
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • CHINA
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 28: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 30: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • EUROPE
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • FRANCE
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 40: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • GERMANY
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • ITALY
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • UNITED KINGDOM
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 52: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030

IV. COMPETITION